Improving Neurologic Outcomes after Sudden Cardiac Arrest
Michigan Resuscitation Innovation and Science Enterprise (M-RISE) is a new research program with the mission to discover, translate and implement innovative therapies focused on preventing brain damage caused by cardiac arrest.
“Survival for these patients decreases with every minute there is a delay in therapy,” says Robert Neumar, MD, PhD, professor and chair of emergency medicine at Michigan Medicine and director of M-RISE. “Many patients who have their heart restarted will subsequently die from severe brain damage, and many who do survive to hospital discharge do not return to their pre-arrest function due to brain injury.”
M-RISE is funded by the American Heart Association (AHA) and a part of its Arrhythmias and Sudden Cardiac Death Strategically Focused Research Network, which works to support researchers leading new approaches to studying arrhythmias and sudden cardiac death.